Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20191106045347N1Phase 2Completed
Phase 2, randomised, open-label trial in Uterine hypercontractility comparing Intravenous magnesium sulfate with Sublingual nitroglycerin spray (2 arms). Primary endpoints: Extra uterine contractions, Heart rate deficit and 4 more. Started May 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20191106045347N1.